Browsing by Author "Hassan, O. O."

Now showing 1 - 4 of 4

Impact of dietary intervention on selected biochemical indices of inflammation and oxidative stress in Nigerians with metabolic syndrome: a pilot study
(2014) Rahamon, S. K.; Charles-Davies, M. A.; Akinlade, K. S.; Olaniyi, J. A.; Fasanmade, A. A.; Oyewole, O. E.; Owolabi, M. O.; Adebusuyi, J. R.; Hassan, O. O.; Ajobo, B. M.; Ebesunun, M. O.; Adigun, K.; Fabian, U. A.; Popoola, O. O.; Okunbolade, W.; Arinola, O. G.; Agbedana, E. O.
Aim: This study assessed the impact of dietary modification on cardiometabolic, inflammatory and oxidative stress indices in Nigerians with metabolic syndrome (MS). Subjects and Methods: Sixty participants with MS were selected using the International Diabetes Federation criteria from a cohort participating in “Risk Assessment of Type 2 diabetes mellitus and Dementia in Nigerians with Metabolic Syndrome” study. The subjects were seen by a Dietitian and the approximate percentages of total calories from total protein, total fat, polyunsaturated fat, and carbohydrate were calculated from dietary history and pegged at 20%, 30%, 14% and 50% respectively. To ensure compliance, each participant was seen monthly (for 6 months) by the Dietitian. Glucose and lipid profile were determined using enzymatic methods. Serum activities of superoxide dismutase (SOD), catalase (CAT), Myeloperoxidase (MPO) and levels of nitric oxide (NO), malondialdehyde (MDA), hydrogen peroxide (H2O2), total protein and albumin were determined using spectrophotometric methods while high sensitivity C-reactive protein (hsCRP) and tumuor necrosis factor-alpha (TNF-α) were determined using ELISA. Student’s t-test (paired) and Wilcoxon signed-rank test were used for statistical analysis as appropriate. P-value <0.05 was considered significant. Results: The mean blood pressure (BP), body mass index (BMI), waist circumference(WC), hip circumference (HC), body fat, NO, hsCRP, H2O2, total protein and globulin were significantly reduced while the mean HDL, MDA, albumin and activities of CAT and MPO were significantly increased post-dietary modification compared with baseline. Conclusion: Short-term dietary intervention improved cardiovascular risk, inflammation and oxidative stress indices in Nigerians with MS.
Indices of metabolic syndrome in 534 apparently healthy traders
(David Publishing, 2012-02) Charles-Davies, M. A.; Arinola, O. G.; Fasanmade, A. A.; Olaniyi, J. A.; Oyewole, O. E.; Owolabi, M. O.; Hassan, O. O.; Ajobo, M. T.; Adigun, K.; Akinlade, K. S.; Adebusuyi, J. R.; Ebesunun, M. O.; Popoola, O. O.; Okunbolade, W.; Fabian, U. A.; Rahamon, S. K.; Ogunlakin, M. A.; Agbedana, E. O.
Background: Metabolic Syndrome (MS) increases the risk of developing type-2 diabetes (DM2) and cardiovascular diseases (CVD) and it is thought to be prevalent in Nigeria. This study aims at determining the prevalence of MS and its component risk factors among apparently healthy traders in a local market in Ibadan, Nigeria. Methods: 534 apparently healthy traders from a local market in Bodija, Ibadan, Nigeria aged (18–105) years with neither DM2 nor CVD were participants of a cohort study on risk assessment of type 2 diabetes and dementia in Nigerians with metabolic syndrome. The International Diabetes Federation (2005) and the World Health Organisation (1998) criteria were used for MS and BMI respectively. Anthropometric indices (weight, height, body mass index (BMI), percentage body fat (PBF), waist and hip circumferences (WC & HC) and their ratio (WHR), waist circumference to height ratio (WHT)) and blood pressure (BP) were obtained by standard methods. Blood samples (6 ml) were obtained for the determination of glucose (FPG), total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C) by enzymatic methods while low density lipoprotein cholesterol (LDL-C) was calculated. Descriptive statistics, Chi-square test and ANOVA were among the analyses conducted. Results: 301 (56.4%) of traders studied were overweight (176, 33.0%) or obese (125, 23.4%) while 17 (3.4%) and 125 (40.4%) were underweight and normal weight respectively. The prevalence of MS and obesity were 87 (16.3%) and 125 (23.4%) respectively. There was significant association between obesity and MS (p < 0.05). Both MS and obesity were significantly associated with gender (p < 0.05). The prevalence of MS and obesity was higher in female (20.9%; 31.0%) than male traders (6.5%; 7.1%) respectively. The prevalence of MS increased from normal weight (8.3%) to overweight (18.8%) to obesity (28.8%). There were significantly higher differences in age, BP(systolic and diastolic), weight, BMI, WC, HC, WHT, WHR, and PBF but lower difference in height when overweight/obese groups were compared with normal weight group (p < 0.05). TC and LDL-C were significantly higher in only obese than normal weight traders. However, FPG, TG and HDL-C were similar in all groups (p >0.05). Conclusion: There is high prevalence of MS and obesity among Nigerian traders. Female gender, hypercholesterolemia, hypertension, increasing age, general and abdominal obesity appear to be important metabolic risk factors of CVD and not DM2 among Nigerian traders. Health care strategies for effective modulation of diet and lifestyle are needed urgently. In addition, screening programs for indices of MS in all Nigerians irrespective of BMI could be considered.
Leptin concentrations in African blacks with metabolic syndrome and Type 2 diabetes mellitus
(David Publishing, 2011) Fabian, U. A.; Charles-Davies, M. A.; Adebusuyi, J. R.; Ebesunun, M. O.; Ajobo, B. M.; Hassan, O. O.; Adigun, K.; Owolabi, M. O.; Oyewole, O. E.; Olaniyi, J. A.; Fasanmade, A. A.; Akinlade, K. S.; Arinola, O. G.; Agbedana, E. O.
Background: Mortality rate from metabolic/cardiometabolic syndromes (MS/CMS) and type 2 diabetes mellitus (DM2) are highly prevalent in African blacks known with higher mortality from cardiovascular diseases than caucasians. Leptin, a satiety-regulating hormone increases in obesity and is associated with cardiovascular risk and prediction of MS. This study is designed to evaluate leptin in Nigerians with MS and DM2 to assist in the early diagnosis and prevention of metabolic diseases. Methods: 136 participants (45 with MS, 47 with DM2 and 44 apparently healthy individuals (controls)) aged 18-80 years were included in a cohort study at the University College Hospital, Ibadan. Measures of adiposity-%body fat, body mass index (BMI), waist and hip circumferences (WC and HC respectively), waist to hip ratio (WHR), and blood pressure were obtained by standard methods. 10 ml of blood were obtained from each participant after an overnight fast (10-14 h) and analysed for leptin, total cholesterol (TC), triglycerides (TG), high density lipoprotein (HDL), and glucose by standard methods while low density lipoprotein (LDL) was calculated. Data obtained were analysed statistically with SPSS software version 16.0. Results: Weight, BMI, WC, HC, WHR, %body fat, blood pressure, TG, LDL-C, and glucose were significantly higher while HDL-C was significantly lower in individuals with MS and DM2 compared with controls (p<0.039). Leptin levels were significantly higher in MS group and not in DM2 group when compared with controls (p=0.000). Leptin did not correlate with any of the biochemical indices (p>0.05) tested but correlated significantly with different measures of adiposity in all groups. Leptin correlated negatively but significantly with blood pressure in MS group only. Conclusion: Increases in leptin levels in both MS and DM2 groups might reflect adiposity. Observed high leptin levels in MS group might be a compensatory mechanism for maintenance of weight/fat loss and blood pressure. Its routine analysis may assist in assessing adiposity associated with MS and DM2 for probable prevention of metabolic diseases.
Male sexual dysfunction, leptin, pituitary and gonadal hormones in Nigerian males with metabolic syndrome and type 2 diabetes mellitus
(Avicenna Research Institute, 2016) Fabian, U. A.; Charles-Davies, M. A.; Fasanmade, A. A.; Olaniyi, J. A.; Oyewole, O. E.; Owolabi, M. O.; Owolabi, M. O.; Adebusuyi, J. R; Hassan, O. O.; Ajobo, B. M.; Ebesunun, M. O.; Adigun, K.; Akinlade, K. S.; Arinola, O. G.; Agbedana, E. O.
Background: Pituitary and gonadal dysfunctions resulting from increased adiposity leading to disturbances of sexual and reproductive functions have been reported in males with metabolic syndrome (MS) and type 2 diabetes mellitus (DM2). The aim of this study was to evaluate sexual dysfunction, leptin, and reproductive hormones in Nigerian males with MS and DM2. Methods: Participants were 104 men (34 males with DM2, 17 men with MS and 53 men with normal body mass index (18.5-24.9 Kg/m2) without MS (controls)). The International Diabetes Federation (2005) criteria were used for MS diagnosis. Reproductive history, anthropometry, blood pressure (BP) and 10 ml fasting blood samples were obtained by standard methods. Fasting plasma glucose, total cholesterol, triglycerides and high density lipoprotein cholesterol were determined by enzymatic methods while low density lipoprotein cholesterol was calculated. Leptin, follicle stimulating hormone (FSH), luteinising hormone (LH), prolactin, testosterone and oestrogen were determined by enzyme immunoassay (leptin by Diagnostic Automation, Inc.; others by Immunometrics (UK) Ltd.) while oestrogen-testosterone ratio was calculated. Data analyzed using ANOVA, Chi square and multiple regression were statistically significant at p<0.05. Results: Testosterone was significantly lower in MS than controls while oestradiol and ETR were significantly higher in MS compared with controls and DM2 group (p<0.05). ETR significantly predicted testosterone in all groups (p<0.05). Significantly lower libido was observed in men in MS than controls and DM2 groups (p<0.05). Conclusion: Sexual and reproductive dysfunction may be related to increased conversion of testosterone to oestrogen in increased adipose mass in men with metabolic syndrome and type 2 diabetes mellitus.